Therapeutic Effects of Caplacizumab

By specifically blocking the interaction between von Willebrand factor (vWF) and platelets, caplacizumab can effectively reduce platelet adhesion and consumption, thereby improving the patient's coagulation function.

Improvement of Quality of Life

Caplacizumab can also significantly improve patients' quality of life. Patients with aTTP often face severe issues such as thrombocytopenia, bleeding tendency, and organ function impairment. These problems not only affect the patients' physical health but also cause severe impacts on their psychological and social functions. Caplacizumab enables patients to recover their platelet count more quickly and reduces the occurrence of bleeding events.

Long-Term Efficacy and Safety

The long-term efficacy and safety of caplacizumab are also key concerns for patients and the medical community. Caplacizumab has shown significant long-term efficacy and good safety in the treatment of aTTP.

What is the Price of Caplacizumab?

The price of caplacizumab varies depending on regions, manufacturers, and sales channels.

Price Overview

The main original caplacizumab product on the market is manufactured by Sanofi (France), with a price of approximately USD 4,197 per box. This price is undoubtedly a considerable expense for many patients, especially when long-term treatment is required. The above price is for reference only.

Factors Affecting the Price

The price of caplacizumab is influenced by a variety of factors. R&D costs are one of the important factors determining the drug price. As a nanobody drug, the R&D process of caplacizumab is complex and time-consuming, requiring substantial investment in human, material, and financial resources. Additionally, factors such as market supply and demand, policies and regulations, and the competitive environment also have an impact on the price of caplacizumab.

Procurement Channels for Caplacizumab

Caplacizumab is a prescription drug and must be obtained through professional medical channels.

Formal Medical Institutions

For patients in need of purchasing caplacizumab, formal medical institutions are the preferred procurement channel. Under the guidance of doctors, patients can purchase caplacizumab through hospital pharmacies or designated drug suppliers. During the purchase process, patients should carefully check the drug's name, specification, manufacturer, and expiration date.

Online Pharmaceutical Sales Platforms

With the development of the Internet, online pharmaceutical sales platforms have gradually become a new option for patients to purchase drugs. Patients should be extremely cautious when choosing online platforms. They can also communicate with the platform's customer service to obtain detailed information about the drug and the purchase process.

It should be noted that caplacizumab also has certain adverse reactions and potential risks. During the use of the drug, it is necessary to closely monitor changes in the patient's condition and the occurrence of adverse reactions